NCT05111847

Brief Summary

The purpose of this clinical investigation is to test the safety and performance of short- and longterm Baseplates constructed with different types of biocompatible adhesives.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2021

Completed
5 days until next milestone

Study Start

First participant enrolled

October 12, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

November 8, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 23, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 23, 2022

Completed
3.6 years until next milestone

Results Posted

Study results publicly available

January 14, 2026

Completed
Last Updated

January 14, 2026

Status Verified

December 1, 2025

Enrollment Period

8 months

First QC Date

October 7, 2021

Results QC Date

March 8, 2024

Last Update Submit

December 19, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Trans Epidermal Water Loss (TEWL) to Measure Skin-friendliness

    To evaluate the skin barrier functionality (i.e., skin-friendliness) after repeated use of Baseplates (i.e., adhesives) on the skin behind the ear. High levels of TEWL reflects unhealthy skin, i.e. high loss of water that passes from inside a body through the epidermis.

    17-18 days

Secondary Outcomes (1)

  • Skin Reactions

    17-18 days

Study Arms (2)

Short-term Baseplates first then long-term Baseplates

OTHER

Short-term Baseplates - Type A: Acrylate Type B: YUKI-gel Long-term Baseplates - Type C: Hydrocolloid Type D: Silicone

Device: Short-term Baseplates first then long-term Baseplates

Long-term Baseplates first then short-term Baseplates

OTHER

Long-term Baseplates - Type C: Hydrocolloid Type D: Silicone Short-term Baseplates - Type A: Acrylate Type B: YUKI-gel

Device: Long-term Baseplates first then short-term Baseplates

Interventions

Short-term Baseplates A and B tested for 17/18 days first then long-term Baseplates C and D tested for 17/18 days

Short-term Baseplates first then long-term Baseplates

Long-term Baseplates C and D tested for 17/18 days first then short-term Baseplates A and B tested for 17/18 days

Long-term Baseplates first then short-term Baseplates

Eligibility Criteria

Age18 Years - 120 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed consent obtained, and letter of authority signed before any study related activities
  • Are at least 18 years of age and have full legal capacity
  • Healthy skin behind the ear

You may not qualify if:

  • Pregnant or breastfeeding
  • Known allergic responses to the adhesives
  • Treatment with corticosteroids, either as a cream in the area behind the ear or systemically (tablet or injection) within the last month
  • Subject is unable or does not have the necessary assistance to properly operate the device system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dermato-Venerologisk Afdeling og Videncenter for Sårheling, Bispebjerg Hospital

København NV, 2400, Denmark

Location

Limitations and Caveats

The study did not have a formal power and sample size calculation. Some skin reactions were reported both as an ADE and separately in the "skin reaction questionnaire". When recording objective skin measurements, particularly TEWL, it is important that the room conditions, such as temperature and humidity, which may have affected the skin measurements. However, all TEWL measurements were within acceptable range.

Results Point of Contact

Title
Clinical Operations, Medical Affairs
Organization
UNEEG medical

Study Officials

  • Tonny Karlsmark, Dr.

    Bispebjerg Hospital

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: In Part I of the study, the baseplates type A, B, C and D were tested on the skin behind the ears. Each subject tested either 1) short-term baseplates A and B first for 17/18 days and then long-term baseplates C and D for 17/18 days or 2) long-term baseplates C and D first for 17/18 days and then short-term baseplates A and B for 17/18 days.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 7, 2021

First Posted

November 8, 2021

Study Start

October 12, 2021

Primary Completion

June 23, 2022

Study Completion

June 23, 2022

Last Updated

January 14, 2026

Results First Posted

January 14, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations